2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Therapeutics and Clinical Risk Management THER CLIN RISK MANAG (此期刊被最新的JCR期刊SCIE收录) LetPub评分 4.8
50人评分
我要评分
声誉 5.9 影响力 3.6 速度 7.0 | |||||||||||||||||||||||||||||
期刊ISSN | 1176-6336 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||
E-ISSN | 1178-203X | |||||||||||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 2.3 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||
实时影响因子 | 截止2024年10月29日:1.706 | |||||||||||||||||||||||||||||
2023-2024自引率 | 0.00%点击查看自引率趋势图 | |||||||||||||||||||||||||||||
五年影响因子 | 2.3 | |||||||||||||||||||||||||||||
JCI期刊引文指标 | 0.69 | |||||||||||||||||||||||||||||
h-index | 暂无h-index数据 | |||||||||||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||
期刊官方网站 | https://www.dovepress.com/therapeutics-and-clinical-risk-management-journal | |||||||||||||||||||||||||||||
期刊投稿网址 | https://www.dovepress.com/submit_step_1.php | |||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Therapeutics and Clinical Risk Management的语言要求,还能让Therapeutics and Clinical Risk Management编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Therapeutics and Clinical Risk Management编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||
是否OA开放访问 | Yes | |||||||||||||||||||||||||||||
OA期刊相关信息 | 文章处理费:需要( USD3300; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:clinical therapeutics、clinical risk management 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||||||||||
通讯方式 | PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752 | |||||||||||||||||||||||||||||
出版商 | Dove Medical Press | |||||||||||||||||||||||||||||
涉及的研究方向 | Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics | |||||||||||||||||||||||||||||
出版国家或地区 | New Zealand | |||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||
出版周期 | ||||||||||||||||||||||||||||||
出版年份 | 0 | |||||||||||||||||||||||||||||
年文章数 | 90点击查看年文章数趋势图 | |||||||||||||||||||||||||||||
Gold OA文章占比 | 99.36% | |||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 71.11% | |||||||||||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:2区
| |||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1176-6336%5BISSN%5D | |||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: 16 Weeks | |||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: | |||||||||||||||||||||||||||||
版面费/APC文章处理费信息 | 文章处理费:需要( USD3300; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Therapeutics and Clinical Risk Management顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
中国学者近期发表的论文 | |
1. | LncRNA AFAP1-AS1 Induces Gefitinib Resistance of Lung Adenocarcinoma Through the miR-653-5p/AGR2 Axis Author: Zuo, Tao; Jiang, Ping; Fu, Jun; Zhang, Yongjian Journal: THERAPEUTICS AND CLINICAL RISK MANAGEMENT. 2023; Vol. 19, Issue , pp. 1-13. DOI: 10.2147/TCRM.S374162 PubMed DOI |
2. | Research on the Influence of the Allogeneic Bone Graft in Postoperative Recovery After MOWHTO: A Retrospective Study Author: Zhong, Rui; Yu, Gang; Wang, Yingming; Fang, Chao; Lu, Shuai; Liu, Zhilin; Gao, Jingyu; Yan, Chengyuan; Zhao, Qichun Journal: THERAPEUTICS AND CLINICAL RISK MANAGEMENT. 2023; Vol. 19, Issue , pp. 193-205. DOI: 10.2147/TCRM.S400354 PubMed DOI |
3. | Identifying the Risk Factors for Postoperative Sore Throat After Endotracheal Intubation for Oral and Maxillofacial Surgery Author: Zheng, Zhou-peng; Tang, Su-lin; Fu, Shao-lan; Wang, Qian; Jin, Li-wei; Zhang, Yan-li; Huang, Rong-rong Journal: THERAPEUTICS AND CLINICAL RISK MANAGEMENT. 2023; Vol. 19, Issue , pp. 163-170. DOI: 10.2147/TCRM.S396687 PubMed DOI |
4. | Thoracic Paravertebral Block Decreased Body Temperature in Thoracoscopic Lobectomy Patients: A Randomized Controlled Trial Author: Yan, Yanhong; Geng, Jiao; Cui, Xu; Lei, Guiyu; Wu, Lili; Wang, Guyan Journal: THERAPEUTICS AND CLINICAL RISK MANAGEMENT. 2023; Vol. 19, Issue , pp. 67-76. DOI: 10.2147/TCRM.S392961 PubMed DOI |
5. | Advances in Prepectoral Breast Reconstruction Author: Xie, Jiaheng; Yan, Wei; Zhu, Zhechen; Wang, Ming; Shi, Jingping Journal: THERAPEUTICS AND CLINICAL RISK MANAGEMENT. 2023; Vol. 19, Issue , pp. 361-368. DOI: 10.2147/TCRM.S404799 PubMed DOI |
6. | Shifts in Intestinal Metabolic Profile Among Kidney Transplantation Recipients with Antibody-Mediated Rejection Author: Wang, Junpeng; Zhang, Xiaofan; Li, Mengjun; Li, Ruoying; Zhao, Ming Journal: THERAPEUTICS AND CLINICAL RISK MANAGEMENT. 2023; Vol. 19, Issue , pp. 207-217. DOI: 10.2147/TCRM.S401414 PubMed DOI |
7. | Comparison and Optimization of Cardiovascular Risk Scores in Predicting the 4-Year Outcome of Patients with Obstructive Coronary Arteries Disease Author: Qiu, Taichun; Liang, Chunxiao; Ming, Bing; Liu, Gaoyuan; Zhang, Furong; Zeng, Ruxue; Xie, Dongmei; Zou, Qing Journal: THERAPEUTICS AND CLINICAL RISK MANAGEMENT. 2023; Vol. 19, Issue , pp. 319-328. DOI: 10.2147/TCRM.S404351 PubMed DOI |
8. | An Individualized Red Blood Cell Transfusion Strategy Using Pediatric Perioperative-Transfusion-Trigger Score Reduced Perioperative Blood Exposure for Children: A Randomized Controlled Clinical Trial Author: Luo, Zhen; Li, Yansong; Li, Xiaoqiang; Liao, Ren Journal: THERAPEUTICS AND CLINICAL RISK MANAGEMENT. 2023; Vol. 19, Issue , pp. 229-237. DOI: 10.2147/TCRM.S388924 PubMed DOI |
9. | Evaluating Efficacy and Safety of Tacrolimus Treatment in Membranous Nephropathy: Results of a Retrospective Study of 182 Patients Author: Liang, Shuang; Liang, Yan-Jun; Li, Zhao; Wang, Yong; Guo, Xin-Ru; Zhang, Chao-yang; Zhang, Chun; Wu, Jie; Wang, Xiao-Long; Li, Yi-Sha; Cai, Guang-Yan; Chen, Xiang-Mei Journal: THERAPEUTICS AND CLINICAL RISK MANAGEMENT. 2023; Vol. 19, Issue , pp. 351-360. DOI: 10.2147/TCRM.S399218 PubMed DOI |
10. | Bone Remodelling of the Proximal Femur After Hip Revision with a Metaphyseal-Fixation Femoral Stem Component Author: Li, Zhijie; Li, Mengnan; Yao, Xiaowei; Liu, Bo; Liu, Sikai; Liu, Zeming; Zhang, Binquan; Han, Yongtai Journal: THERAPEUTICS AND CLINICAL RISK MANAGEMENT. 2023; Vol. 19, Issue , pp. 171-181. DOI: 10.2147/TCRM.S393876 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室